Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease

BACKGROUND: Phosphorylated tau (p-tau) epitopes in cerebrospinal fluid (CSF) are accurate biomarkers for a pathological and clinical diagnosis of Alzheimer's disease (AD) and are seen to be increased in preclinical stage of the disease. However, it is unknown if these increases transpire earlie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashton, Nicholas J., Benedet, Andréa L., Pascoal, Tharick A., Karikari, Thomas K., Lantero-Rodriguez, Juan, Brum, Wagner S., Mathotaarachchi, Sulantha, Therriault, Joseph, Savard, Melissa, Chamoun, Mira, Stoops, Erik, Francois, Cindy, Vanmechelen, Eugeen, Gauthier, Serge, Zimmer, Eduardo R., Zetterberg, Henrik, Blennow, Kaj, Rosa-Neto, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850760/
https://www.ncbi.nlm.nih.gov/pubmed/35158308
http://dx.doi.org/10.1016/j.ebiom.2022.103836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850760/
https://www.ncbi.nlm.nih.gov/pubmed/35158308
http://dx.doi.org/10.1016/j.ebiom.2022.103836

Ejemplares similares